OASIS Wound Matrix (Oasis) Mechanism of Action

Healthpoint

Status and phase: Completed; Phase 4

Conditions: Venous Stasis Ulcers (VSU); Diabetic Foot Ulcers (DFU)

Treatments: Device: OASIS Wound Matrix

Study type: Interventional

Funder types: Industry

Identifiers

NCT00570141

9310-002-004

Details and patient eligibility

About

OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.

Full description

Wound types will be Diabetic Foot Ulcers (DFU) and Venous Stasis Ulcers (VSU).

Enrollment: 13 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetic foot ulcer (DFU) or venous stasis ulcer (VSU) of the leg, with certain restrictions on size, duration and underlying health

Exclusion criteria

• Contraindications or hypersensitivity to the use of the study medications or their components

Trial design

13 participants in 1 patient group

OASIS Wound Matrix (Oasis)

Active Comparator group

Description:

This is a single arm study with only the test article Oasis used on all subjects

Treatment:

Device: OASIS Wound Matrix